New drugs and drug types boost hope for the future. Report from ICAAC.
HIV-infected patients who are failing current antiretroviral regimens and their clinicians have new cause for hope as HIV researchers are drawing closer to bringing some potent new drugs to the market. Entry inhibitors, integrase inhibitors, and other new antiretrovirals were highlighted at the 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy in San Diego. HIV experts call the news very encouraging.